Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Overview
- What constitutes and characterizes asthma?
- Airway inflammation
- What constitutes inflammation in asthma?
- Multiple components of inflammation in asthma
- Components of inflammation in asthma
- Key components of inflammation in asthma
- Mast cells in asthma
- The role of mast cells in asthma
- Biology of the airway response to antigen
- What happens if the mast cell is "disarmed"?
- Treatment with omalizumab on IgE-bearing cells
- Omalizumab effect on asthma - reference
- Omalizumab effect on asthma - study results
- Omalizumab effect on asthma exacerbations
- Omalizumab effect on asthma over a year
- Allergic sensitization and "September epidemics"
- What is the role of the eosinophil in asthma?
- Eosinophil
- Actions of IL-5
- Removing one of the inflammatory cells (1)
- The effect on lung function
- Mepolizumab reduces exacerbations
- Lymphocyte role in asthma
- Sub-populations of lymphocytes in asthma
- IL-4/13 actions
- IL-13 importance
- Gene expression microarray
- Expression of three genes induced by IL-13
- Expression levels of the Th2 cytokines
- Th2 high asthma patience response
- Responsiveness to inhaled steroids
- Characteristics of Th2-asthma phenotype
- Anti IL-13 effect
- Anti IL-13 study results
- Eosinophil sub populations
- Regulatory T cells
- TGF-beta
- Activating regulatory pathways
- Th17
- Th17 effect on asthma
- IL-17 and asthma
- Neutrophils and asthma
- IL-33 pathway
- IL-33
- IL-13 enhancing activity
- Summary
Topics Covered
- Airway inflammation is a complex, interactive, redundant immune response
- Components of inflammation in asthma
- "Traditional" inflammatory cells in airway inflammation
- Mast cells and eosinophils
- Lymphocytes
- Using monoclonal antibodies to gain insight into the clinical significance of inflammation in asthma
- IgE, IL-5, and IL-13
- The diversity of patterns of inflammation in asthma
- Personalized medicine
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Busse, W. (2012, February 19). Advances in asthma: airway inflammation [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 11, 2024, from https://doi.org/10.69645/XHFT8756.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. William Busse has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.